|
30
|
127
|
7kriA |
Fr6-bound sars-cov-2 nsp9 rna-replicase |
|
24
|
72
|
7egqC |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
86
|
301
|
7fayA |
Crystal structure of sars-cov-2 main protease in complex with (r)-1a |
|
227
|
926
|
7egqA |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
57
|
187
|
7egqB |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
3
|
20
|
7et3H |
C5 portal vertex in the enveloped virion capsid |
|
7
|
20
|
7etjH |
C5 portal vertex in the partially-enveloped virion capsid |
|
5
|
20
|
7etoH |
C1 cvsc-binding penton vertex in the virion capsid of human cytomegalovirus |
|
84
|
301
|
7fazA |
Crystal structure of the sars-cov-2 main protease in complex with y180 |
|
20
|
131
|
7egqH |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
92
|
523
|
7egqK |
Co-transcriptional capping machineries in sars-cov-2 rtc: coupling of n7-methyltransferase and 3'-5' exoribonuclease with polymerase reveals mechanisms for capping and proofreading |
|
89
|
301
|
7nw2A |
Crystal structure of sars-cov-2 main protease in complex with lon-wei-adc59df6-47 |
|
88
|
300
|
7einA |
Sars-cov-2 main proteinase complex with microbial metabolite leupeptin |
|
81
|
306
|
7lcoA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
83
|
306
|
7lctA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
83
|
306
|
7ldlA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
83
|
298
|
7k0hA |
1.70 a resolution structure of sars-cov 3cl protease in complex with a deuterated gc376 alpha-ketoamide analog (compound 5) |
|
61
|
235
|
7mc9A |
X-ray structure of pedv papain-like protease 2 bound to ub-pa |
|
80
|
306
|
7lcsA |
Improved feline drugs as sars-cov-2 mpro inhibitors: structure-activity studies & micellar solubilization for enhanced bioavailability |
|
86
|
299
|
7k0eA |
1.90 a resolution structure of sars-cov-2 3cl protease in complex with deuterated gc376 |
|
82
|
302
|
7k0gA |
1.85 a resolution structure of sars-cov 3cl protease in complex with deuterated gc376 |
|
89
|
305
|
7aehA |
Sars-cov-2 main protease in a covalent complex with a pyridine derivative of abt-957, compound 1 |
|
89
|
305
|
7aegA |
Sars-cov-2 main protease in a covalent complex with sdz 224015 derivative, compound 5 |
|
82
|
301
|
7m8zA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 29 |
|
85
|
302
|
7m8xA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 6 |
|
77
|
305
|
7m90A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 50 |
|
85
|
305
|
7m91A |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 25 |
|
86
|
301
|
7m8mA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 11 |
|
84
|
306
|
7n8cA |
Joint x-ray/neutron structure of sars-cov-2 main protease (mpro) in complex with mcule5948770040 |
|
28
|
120
|
7nh7B |
Oc43 coronavirus methyltransferase |
|
82
|
301
|
7mgrA |
Sars-cov-2 main protease in complex with nsp8/9 substrate peptide |
|
88
|
306
|
7m8yA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 15 |
|
85
|
301
|
7m8oA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 19 |
|
82
|
306
|
7n89A |
Room-temperature x-ray structure of sars-cov-2 main protease c145a mutant in complex with substrate ac-savlqsgf-conh2 |
|
85
|
301
|
7m8nA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 16 |
|
89
|
295
|
7nh7A |
Oc43 coronavirus methyltransferase |
|
84
|
301
|
7m8pA |
Crystal structure of the sars-cov-2(2019-ncov) main protease in complex with compound 23 |
|
87
|
305
|
7mgsA |
Sars-cov-2 main protease in complex with n-terminal autoprocessing substrate |
|
92
|
306
|
7cuuA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with mg132 |
|
85
|
301
|
7dk1A |
Crystal structure of zinc bound sars-cov-2 main protease |
|
51
|
259
|
6z90A |
Crystal structure of mindy1 mutant-p138a |
|
85
|
305
|
7e19A |
Crystal structure of sar-cov-2 3cl protease complex with inhibitor sh-5 |
|
84
|
303
|
7e18A |
Crystal structure of sar-cov-2 3cl protease complex with inhibitor yh-53 |
|
80
|
301
|
7cutA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with z-vad-fmk |
|
80
|
305
|
7nt3A |
Crystal structure of sars cov2 main protease in complex with fscu015 |
|
32
|
111
|
7ms6A |
Structure of usp5 zinc-finger ubiquitin binding domain co-crystallized with (2-fluoro-4-((4-phenylpiperidin-1-yl)sulfonyl)benzoyl)glycine |
|
91
|
306
|
7n5zA |
Sars-cov-2 main protease c145s mutant |
|
82
|
305
|
7nt1A |
Crystal structure of sars cov2 main protease in complex with fsp007 |
|
29
|
113
|
7ms7A |
Structure of usp5 zinc-finger ubiquitin binding domain co-crystallized with (5-((4-(4-chlorophenyl)piperidin-1-yl)sulfonyl)picolinoyl)glycine |
|
81
|
306
|
7n6nA |
Sars-cov-2 main protease c145s mutant in complex with n and c-terminal residues |
